← All FR Documents
Notice

National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

📖 Research Context From Federal Register API

Key Dates
Citation: 90 FR 12329
April 1-2, 2025.
Public Participation

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, National Institutes of Health. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

April 1-2, 2025.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2025-04293
FR Citation90 FR 12329
TypeNotice
PublishedMar 17, 2025
Effective Date-
RIN-
Docket ID-
Pages12329–12330 (2 pages)
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

  • Incorporate requirements by reference (IBR) to external documents
  • Are procedural notices without substantive obligations
  • Contain only preamble/explanation without regulatory text

Full Document Text (609 words · ~4 min read)

Text Preserved
<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>National Institutes of Health</SUBAGY> <SUBJECT>National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings</SUBJECT> Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. <EXTRACT> <E T="03">Name of Committee:</E> National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; National Institute of Diabetes and Digestive and Kidney Diseases Small Business Innovation Research/Small Business Technology Transfer Special Emphasis Panel. <E T="03">Date:</E> April 1-2, 2025. <E T="03">Time:</E> 10:00 a.m. to 5:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Cheryl Nordstrom, Ph.D., MPH, Scientific Review Officer, Scientific Review Branch, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 7013, Bethesda, MD 20892, 301-402-6711, <E T="03">cheryl.nordstrom@nih.gov.</E> <E T="03">Name of Committee:</E> National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; RC2 Review. <E T="03">Date:</E> April 8, 2025. <E T="03">Time:</E> 10:30 a.m. to 1:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Ann Jerkins, Ph.D., Scientific Review Officer, Review Branch, Division of Extramural Research, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Room 7119, Bethesda, MD 20892, 301-594-2242, <E T="03">jerkinsa@niddk.nih.gov.</E> <E T="03">Name of Committee:</E> National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Small Business Innovation Research Special Emphasis Panel. <E T="03">Date:</E> April 9-10, 2025. <E T="03">Time:</E> 12:00 p.m. to 5:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Michele Barnard, Ph.D., Scientific Review Officer, Review Branch, Division of Extramural Research, National Institutes of Health,National Institute of Diabetes and Digestive and Kidney Diseases, Room 7353, Bethesda, MD 20892, (301) 594-8898, <E T="03">barnardm@extra.niddk.nih.gov.</E> <E T="03">Name of Committee:</E> National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Small Business Innovation Research. <E T="03">Date:</E> April 24-25, 2025. <E T="03">Time:</E> 10:00 a.m. to 5:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Ann Jerkins, Ph.D., Scientific Review Officer, Review Branch, Division of Extramural Research, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Room 7119, Bethesda, MD 20892, 301-594-2242, <E T="03">jerkinsa@niddk.nih.gov.</E> <FP>(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)</FP> </EXTRACT> <SIG> <DATED>Dated: March 12, 2025.</DATED> <NAME>Melanie J. Pantoja,</NAME> Program Analyst, Office of Federal Advisory Committee Policy. </SIG> <FRDOC>[FR Doc. 2025-04293 Filed 3-14-25; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison.